14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.0060 $169.56 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Apr 05, 2016 $28.74 $30.33 $28.60 $29.90 424 005
Apr 04, 2016 $27.36 $29.67 $27.02 $29.21 453 927
Apr 01, 2016 $26.15 $27.42 $25.49 $27.34 363 228
Mar 31, 2016 $26.05 $27.14 $25.69 $26.39 368 786
Mar 30, 2016 $26.01 $27.69 $25.22 $25.95 266 562
Mar 29, 2016 $23.89 $25.95 $23.20 $25.76 391 300
Mar 28, 2016 $24.20 $24.64 $23.10 $23.92 283 500
Mar 24, 2016 $24.60 $25.21 $23.13 $24.21 415 000
Mar 23, 2016 $27.45 $28.12 $24.45 $24.46 463 300
Mar 22, 2016 $26.15 $28.08 $25.90 $27.62 354 700
Mar 21, 2016 $25.21 $27.16 $24.82 $26.39 341 200
Mar 18, 2016 $23.74 $25.46 $23.18 $25.31 752 400
Mar 17, 2016 $24.73 $25.08 $22.67 $23.64 423 600
Mar 16, 2016 $25.34 $26.18 $24.12 $24.87 415 600
Mar 15, 2016 $26.97 $27.99 $25.02 $25.49 330 700
Mar 14, 2016 $26.87 $28.03 $26.81 $27.26 410 300
Mar 11, 2016 $26.25 $26.93 $25.40 $26.87 328 000
Mar 10, 2016 $27.63 $28.95 $25.74 $26.02 368 200
Mar 09, 2016 $27.82 $28.22 $26.10 $27.36 537 400
Mar 08, 2016 $29.59 $30.10 $27.59 $27.74 360 000
Mar 07, 2016 $28.28 $30.56 $27.85 $29.78 537 900
Mar 04, 2016 $27.90 $29.41 $27.33 $28.47 343 400
Mar 03, 2016 $27.59 $28.45 $27.35 $27.97 327 100
Mar 02, 2016 $27.08 $28.27 $26.89 $27.65 507 000
Mar 01, 2016 $25.57 $27.25 $25.11 $27.25 478 900
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT